- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07364500
Protocol-driven Nutrition in Preterm Infants
Early Detection and Prevention of Health Complications in Premature Infants - Protocol-driven Nutrition
The project is a national, prospective, multicenter, interventional pilot project focused on protocol-driven nutrition in preterm infants in the Czech republic.
The primary aim of the project is to prepare, test, and develop a proposal for a national methodology for the care of preterm newborns in the field of nutrition. This will reduce health risks in premature infants and minimize the negative impacts on the overall development of the child and the family of the premature infant.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The project is a national, prospective, multicenter, interventional pilot project focused on protocol-driven nutrition in preterm infants in the Czech republic.
The main goal of the project is standardization of nutrition of premature newborns across healthcare facilities with the aim to optimize postnatal growth and reduce complications associated with prematurity through individualized and closely monitored nutritional plans.
The project will be running in 5 perinatology centers in the Czech Republic. It is expected that 400 premature infants will participate. The project is supported by the European Social Fund (Operational Program Employment Plus) and the state budget of the Czech Republic and is registered by the Ministry of Labour and Social Affairs of the Czech Republic under ID: CZ.03.02.02/00/22_005/0002020. The study has been reviewed and approved by multiple local ethical committees. The listed IRB represents the lead national ethical committee overseeing the trial.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Daniela Dokoupilová, MSc
- Phone Number: +420725441408
- Email: daniela.dokoupilova@uzis.cz
Study Contact Backup
- Name: Lucie Mandelová, Ph.D.
- Phone Number: +420770190828
- Email: lucie.mandelova@uzis.cz
Study Locations
-
-
-
Zlín, Czechia
- Recruiting
- Tomas Bata Regional Hospital in Zlin
-
Contact:
- Marcela Pekařová, MD
- Email: marcela.pekarova@bnzlin.cz
-
-
Czech Republic
-
Brno, Czech Republic, Czechia
- Not yet recruiting
- Brno University Hospital
-
Contact:
- Kateřina Fojtíková, MD
- Email: fojtikova.katerina@fnbrno.cz
-
Olomouc, Czech Republic, Czechia
- Recruiting
- University Hospital Olomouc
-
Contact:
- Martin Wita, MD
- Email: martin.wita@fnol.cz
-
Prague, Czech Republic, Czechia
- Recruiting
- General University Hospital
-
Contact:
- Blanka Zlatohlavková, MD
- Email: blanka.zlatohlavkova@vfn.cz
-
České Budějovice, Czech Republic, Czechia
- Recruiting
- Ceske Budejovice Hospital
-
Contact:
- Jiří Dušek, MD
- Email: dusek.jiri@nemcb.cz
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Infants born before 31+6 weeks gestation.
- Signed consent for participation in the project and consent for the processing of personal data.
- Admission to neonatal care in the participating hospital within 24 hours after birth.
Exclusion Criteria:
- Congenital malformations.
- Fetal hydrops.
- Intraventricular hemorrhage requiring drainage.
- Necrotizing enterocolitis requiring surgical treatment.
- Surgically treated hydrocephalus.
- Unsigned consent for participation in the project and/or consent for the processing of personal data.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Preterm infants
The nutritional management of enrolled patients will be guided by individualized plans developed by attending physicians, supported by advanced clinical nutrition software enabling precise monitoring and adjustment based on ongoing anthropometric and dietary data.
|
Infants undergo regular anthropometric assessments (weight, length, head circumference), and detailed fluid and nutrient intake is recorded. Weekly analysis of the macronutrient composition of maternal or donor milk is conducted, enabling personalized fortification to meet the infant's current needs. The intervention utilizes a dedicated nutrition software tool, incorporating Fenton growth charts, to support clinical decisions and track progress via z-scores compared to term-born infants. By aligning nutrient supply with individual requirements and promoting early enteral feeding, the project seeks to enhance growth outcomes, minimize risks such as bronchopulmonary dysplasia or retinopathy, and shorten the length of stay in neonatal intensive care. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Z-score for body weight at 36 weeks corrected gestational age
Time Frame: Up to a corrected gestational age of 36 weeks
|
Up to a corrected gestational age of 36 weeks
|
|
Z-score for body length at 36 weeks corrected gestational age
Time Frame: Up to a corrected gestational age of 36 weeks
|
Up to a corrected gestational age of 36 weeks
|
|
Z-score for head circumference at 36 weeks corrected gestational age
Time Frame: Up to a corrected gestational age of 36 weeks
|
Up to a corrected gestational age of 36 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Richard Plavka, prof., General Hospital University in Prague
- Study Chair: Jiří Dušek, M.D., MHA, Ceske Budejovice Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- UZIS 2025/2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Infants
-
Chang Gung University of Science and TechnologyRecruitingPreterm InfantsTaiwan
-
University of Colorado, DenverColorado State UniversityRecruitingNeonates and Preterm Infants | CardiopulmonaryUnited States
-
Hadassah Medical OrganizationWithdrawnPreterm Infants With White Matter Damage | Preterm Infants Developing Normally
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingNeonates and Preterm Infants | Catherization | Simulator Training
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinNot yet recruitingVery Preterm Infants Born < 30 Weeks of GestationFrance
-
Ain Shams UniversityRecruitingNeonatal Prematurity | Patent Ductus Arteriosus in Preterm Infants | ProstaglandinsEgypt
-
Ain Shams UniversityCompletedRole of Oral Care in Mechanically Ventilated Preterm InfantsEgypt
-
Bozok UniversityCompletedSleep | Preterm InfantsTurkey
-
Services Institute of Medical Sciences, PakistanCompletedPreterm Infants | Low Birth Weight InfantsPakistan
-
Assistance Publique Hopitaux De MarseilleCompleted
Clinical Trials on Nutrition plan supported by advanced clinical nutrition software
-
Victory Nutrition International, Inc.RecruitingAthletic PerformanceUnited States
-
Beijing Anzhen HospitalBeijing Chao Yang Hospital; Cangzhou Central Hospital; Health Community Group...RecruitingPrehypertension | Prediabetes | Overweight , Obesity | Borderline DyslipidemiaChina
-
Mayo ClinicRecruitingAdvanced Malignant Solid NeoplasmUnited States
-
University of LeicesterUniversity of Leeds; University of Oxford; University of ManchesterRecruitingDiabetes Mellitus, Type 2 | Heart Failure, Diastolic | Heart Failure With Preserved Ejection Fraction | Diabetes Mellitus Type 2 in Obese | Obesity Adult OnsetUnited Kingdom
-
Ohio State UniversityActive, not recruitingSleep DeprivationUnited States